
Daniel Rodriguez
Examiner (ID: 13695, Phone: (571)272-3633 , Office: P/2175 )
| Most Active Art Unit | 2175 |
| Art Unit(s) | 2175, 2178 |
| Total Applications | 615 |
| Issued Applications | 384 |
| Pending Applications | 55 |
| Abandoned Applications | 189 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 961170
[patent_doc_number] => 06951883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-04
[patent_title] => '2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 10/466118
[patent_app_country] => US
[patent_app_date] => 2002-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10279
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466118 | 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof | Jan 20, 2002 | Issued |
Array
(
[id] => 6541523
[patent_doc_number] => 20020193614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Anthranilic acid derivatives as inhibitors of the CGMP-phosphodiesterase'
[patent_app_type] => new
[patent_app_number] => 10/050789
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60334
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050789 | Anthranilic acid derivatives as inhibitors of the CGMP-phosphodiesterase | Jan 17, 2002 | Abandoned |
Array
(
[id] => 1256526
[patent_doc_number] => 06667338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-23
[patent_title] => '9-amino erythromycin derivatives with antibacterial activity'
[patent_app_type] => B2
[patent_app_number] => 10/050837
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18651
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/667/06667338.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050837
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050837 | 9-amino erythromycin derivatives with antibacterial activity | Jan 15, 2002 | Issued |
Array
(
[id] => 1283151
[patent_doc_number] => 06642396
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Process for the production of furfural from lignosulphonate waste liquor'
[patent_app_type] => B1
[patent_app_number] => 09/958936
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1210
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642396.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958936
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958936 | Process for the production of furfural from lignosulphonate waste liquor | Jan 13, 2002 | Issued |
Array
(
[id] => 1348962
[patent_doc_number] => 06579902
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-17
[patent_title] => 'Ribose-substituted aromatic amides, method for the production and use thereof as medicaments'
[patent_app_type] => B1
[patent_app_number] => 09/980728
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11624
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579902.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980728
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980728 | Ribose-substituted aromatic amides, method for the production and use thereof as medicaments | Jan 8, 2002 | Issued |
Array
(
[id] => 1399527
[patent_doc_number] => 06531503
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'Benzofurane derivatives'
[patent_app_type] => B1
[patent_app_number] => 10/030471
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4204
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030471 | Benzofurane derivatives | Jan 8, 2002 | Issued |
Array
(
[id] => 1451480
[patent_doc_number] => 06455710
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Method for the preparation of pure citalopram'
[patent_app_type] => B1
[patent_app_number] => 10/046126
[patent_app_country] => US
[patent_app_date] => 2002-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2490
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10046126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/046126 | Method for the preparation of pure citalopram | Jan 7, 2002 | Issued |
Array
(
[id] => 7169854
[patent_doc_number] => 20040077712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Process for preparing optically active 2,3-dihydrobenzofuran compounds'
[patent_app_type] => new
[patent_app_number] => 10/451723
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15625
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451723 | Process for preparing optically active 2,3-dihydrobenzofuran compounds | Dec 26, 2001 | Issued |
Array
(
[id] => 1203053
[patent_doc_number] => 06720420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-13
[patent_title] => 'Photochromic oxazine compounds and methods for their manufacture'
[patent_app_type] => B2
[patent_app_number] => 10/029579
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6481
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/720/06720420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029579 | Photochromic oxazine compounds and methods for their manufacture | Dec 20, 2001 | Issued |
Array
(
[id] => 5908639
[patent_doc_number] => 20020143195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Process for the preparation of a-methylenelactones and a-substituted hydrocarbylidene lactones'
[patent_app_type] => new
[patent_app_number] => 10/029566
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9673
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20020143195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029566 | Process for the preparation of a-methylenelactones and a-substituted hydrocarbylidene lactones | Dec 20, 2001 | Issued |
Array
(
[id] => 5969392
[patent_doc_number] => 20020091270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Sulfonamides for treatment of endothelin-mediated disorders'
[patent_app_type] => new
[patent_app_number] => 10/029561
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57904
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091270.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029561 | Sulfonamides for treatment of endothelin-mediated disorders | Dec 19, 2001 | Issued |
| 10/018901 | Chroman derivatives against neurological disorders | Dec 16, 2001 | Abandoned |
Array
(
[id] => 7034373
[patent_doc_number] => 20050032883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Novel substance fki-1083 and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 10/491131
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2876
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491131
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491131 | Substance FKI-1083 and process for producing the same | Dec 10, 2001 | Issued |
Array
(
[id] => 7450428
[patent_doc_number] => 20040010032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => '2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/433639
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4003
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20040010032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433639 | 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof | Dec 9, 2001 | Issued |
Array
(
[id] => 1348975
[patent_doc_number] => 06579903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-17
[patent_title] => 'Klainetins and their derivatives, method for their preparation and use thereof'
[patent_app_type] => B2
[patent_app_number] => 10/000450
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6011
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10000450
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/000450 | Klainetins and their derivatives, method for their preparation and use thereof | Dec 3, 2001 | Issued |
Array
(
[id] => 7645428
[patent_doc_number] => 06472542
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin'
[patent_app_type] => B1
[patent_app_number] => 09/996664
[patent_app_country] => US
[patent_app_date] => 2001-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6235
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472542.pdf
[firstpage_image] =>[orig_patent_app_number] => 09996664
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/996664 | Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin | Nov 28, 2001 | Issued |
Array
(
[id] => 6361479
[patent_doc_number] => 20020058649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Contraception method using competitive progesterone antagonists and novel compounds useful therein'
[patent_app_type] => new
[patent_app_number] => 09/994781
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6242
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058649.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994781
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994781 | Contraception method using competitive progesterone antagonists and novel compounds useful therein | Nov 27, 2001 | Issued |
Array
(
[id] => 1014732
[patent_doc_number] => 06894075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => '4′-demethyl-4′-O-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 10/415366
[patent_app_country] => US
[patent_app_date] => 2001-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16179
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/894/06894075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415366
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415366 | 4′-demethyl-4′-O-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same | Nov 18, 2001 | Issued |
Array
(
[id] => 6762190
[patent_doc_number] => 20030125552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Photochromic oxazine compounds and methods for their manufacture'
[patent_app_type] => new
[patent_app_number] => 10/008787
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4284
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008787
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008787 | Photochromic oxazine compounds and methods for their manufacture | Nov 12, 2001 | Issued |
Array
(
[id] => 5875145
[patent_doc_number] => 20020049337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => '4-(2-AMINO-1-HYDROXYETHYL)OXAZOLINE DERIVATIVE AND METHOD FOR PRODUCING SAME'
[patent_app_type] => new
[patent_app_number] => 09/983978
[patent_app_country] => US
[patent_app_date] => 2001-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11630
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049337.pdf
[firstpage_image] =>[orig_patent_app_number] => 09983978
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/983978 | 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same | Oct 25, 2001 | Issued |